We use analytics to improve your experience. Cookie policy
NYSE · Healthcare · Analyst ratings
Wall Street consensus, the buy/hold/sell mix, and 12-month price targets for TMO — 34 analysts in the latest TECHi feed.
Consensus
Buy
Median target
—
High target
—
Low target
—
Buy & Strong Buy
30/ 34
88% of coverage
Hold
4/ 34
12% of coverage
Sell & Strong Sell
0/ 34
0% of coverage
Consensus read
30 of 34 (88%) carry a Buy or Strong Buy. The consensus target of — implies — from the live tape. Watch for revisions in the next 30 days — a bullish skew that's still revising up is the highest-conviction signal; a bullish skew that's flat-to-down on revisions is consensus catching up to a stock that's run.
Deeper view
For the bull / base / bear scenarios, the TECHi-issued price target, and per-author accuracy on TMO, see the TMO forecast page.
Frequently asked
The TMO Analysis page tracks the sell-side consensus rating (Strong Buy / Buy / Hold / Sell / Strong Sell), the recommendation mix, and the median + average price targets for Thermo Fisher Scientific Inc. updated weekly.
Consensus, median, low, and high 12-month price targets for Thermo Fisher Scientific Inc. are displayed on the Analysis page with implied upside / downside vs the live TMO quote.
Thermo Fisher Scientific Inc.'s next scheduled earnings date — and the analyst EPS / revenue estimates for that quarter — appear at the top of the TMO Analysis page; surprise history is plotted underneath.
TECHi's own analyst notes on Thermo Fisher Scientific Inc. (when published) appear in a dedicated card below the consensus block, with deep links to the full research report.
